A human induced pluripotent stem cell model from a patient with hereditary cerebral small vessel disease carrying a heterozygous R302Q mutation in HTRA1

[1]  O. Onodera,et al.  Patients with heterozygous HTRA1-related cerebral small vessel disease misdiagnosed with other diseases: Two case reports , 2022, Clinical neurology and neurosurgery (Dutch-Flemish ed. Print).

[2]  F. Gao,et al.  Inflammatory biomarkers and cerebral small vessel disease: a community-based cohort study , 2022, Stroke and vascular neurology.

[3]  Hideyuki Okano,et al.  iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders. , 2022, Cell stem cell.

[4]  M. Fukunaga,et al.  Candesartan prevents arteriopathy progression in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy model. , 2021, The Journal of clinical investigation.

[5]  Yicheng Zhu,et al.  HTRA1-related autosomal dominant cerebral small vessel disease , 2020, Chinese medical journal.

[6]  S. Yamanaka.  Pluripotent Stem Cell-Based Cell Therapy-Promise and Challenges. , 2020, Cell stem cell.

[7]  A. Nalini,et al.  HTRA1-Related Cerebral Small Vessel Disease: A Review of the Literature , 2020, Frontiers in Neurology.

[8]  D. Taura,et al.  Human iPS cell-derived mural cells as an in vitro model of hereditary cerebral small vessel disease , 2020, Molecular Brain.

[9]  O. Onodera,et al.  HTRA1 Mutations Identified in Symptomatic Carriers Have the Property of Interfering the Trimer-Dependent Activation Cascade , 2019, Front. Neurol..

[10]  J. O'Brien,et al.  Inflammation and cerebral small vessel disease: A systematic review , 2019, Ageing Research Reviews.

[11]  John H. Zhang,et al.  Cerebral Small Vessel Disease , 2018, Cell transplantation.

[12]  M. Dichgans,et al.  CADASIL brain vessels show a HTRA1 loss-of-function profile , 2018, Acta Neuropathologica.

[13]  Yaping Yan,et al.  Emerging Role of Immunity in Cerebral Small Vessel Disease , 2018, Front. Immunol..

[14]  R. Kuwano,et al.  Distinct molecular mechanisms of HTRA1 mutants in manifesting heterozygotes with CARASIL , 2016, Neurology.

[15]  Hideyuki Okano,et al.  iPS cell technologies: significance and applications to CNS regeneration and disease , 2014, Molecular Brain.

[16]  Shinya Yamanaka,et al.  A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells , 2014, Scientific Reports.

[17]  S. Yamanaka,et al.  An Efficient Nonviral Method to Generate Integration‐Free Human‐Induced Pluripotent Stem Cells from Cord Blood and Peripheral Blood Cells , 2013, Stem cells.

[18]  H. Okano,et al.  Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue , 2012, Molecular Brain.

[19]  Robert J. van Oostenbrugge,et al.  Vascular inflammation in cerebral small vessel disease , 2012, Neurobiology of Aging.

[20]  Yasuko Matsumura,et al.  A more efficient method to generate integration-free human iPS cells , 2011, Nature Methods.

[21]  G. Daley,et al.  Generation of induced pluripotent stem cells from human blood. , 2009, Blood.

[22]  R. Stewart,et al.  Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.

[23]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[24]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[25]  E. Canalis,et al.  Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts. , 1998, The Journal of clinical investigation.

[26]  J. Weissenbach,et al.  Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia , 1996, Nature.

[27]  S. Cole,et al.  Sequences Human Induced Pluripotent Stem Cells Free of Vector and Transgene , 2012 .

[28]  S. Tsuji,et al.  Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. , 2009, The New England journal of medicine.

[29]  R. Arceci.  Generation of induced pluripotent stem cells from human blood , 2009 .

[30]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..